azoxymethane has been researched along with Carcinoma in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (10.00) | 18.7374 |
1990's | 5 (16.67) | 18.2507 |
2000's | 9 (30.00) | 29.6817 |
2010's | 11 (36.67) | 24.3611 |
2020's | 2 (6.67) | 2.80 |
Authors | Studies |
---|---|
Eferl, R; Gushchina, V; Kallay, E; Kupper, N; Manhardt, T; Mesteri, I; Moritsch, S; Müller, C; Piatek, K; Salzmann, M; Schepelmann, M; Vlasaty, A | 1 |
Ando, S; Fukamachi, K; Iinuma, M; Matsumoto, H; Suzui, M; Yoshimoto, E | 1 |
Bravou, V; Champeris Tsaniras, S; Giannou, AD; Gorgoulis, VG; Karousi, F; Lalioti, ME; Lygerou, Z; Nikou, S; Pateras, IS; Patmanidi, AL; Petropoulos, M; Stathopoulos, GT; Taraviras, S; Tserou, P; Villiou, M | 1 |
Chang, YY; Huang, WJ; Jeng, YM; Jhuang, YL; Yang, CY; Yu, IS; Yu, LC | 1 |
Borrelli, F; Cascio, MG; Izzo, AA; Pagano, E; Pertwee, RG; Romano, B | 1 |
Ai, F; Li, G; Li, X; Ma, J; Peng, X; Shen, S; Wang, W; Wang, X; Xiong, W; Zhang, D; Zhang, X; Zheng, D; Zhou, Y | 1 |
Bongiovanni, L; Burocchi, A; Colombo, MP; Danelli, L; Guarnotta, C; Lewis, A; Rigoni, A; Rizzo, A; Sangaletti, S; Silver, AR; Tripodo, C | 1 |
Han, J; Ishibashi, R; Kato, N; Kishikawa, T; Koike, K; Miyazawa, M; Nakagawa, R; Ohno, M; Otsuka, M; Suzuki, N; Takata, A; Wu, J; Yamagami, M; Yoshikawa, T | 1 |
Bugni, JM; Meira, LB; Samson, LD | 1 |
Adachi, S; Hata, K; Hirose, Y; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T; Tsurumi, H | 1 |
Agarwal, R; Singh, RP; Tyagi, A; Velmurugan, B | 1 |
Bouhadjar, M; Bousserouel, S; Gosse, F; Marescaux, J; Raul, F; Soler, L | 1 |
Agarwal, R; Gu, M; Ravichandran, K; Singh, RP; Velmurugan, B | 1 |
Barrett, CW; Chaturvedi, R; Fingleton, B; Fischer, MA; Hiebert, SW; Ning, W; Washington, MK; Williams, A; Williams, CS; Wilson, KT | 1 |
Abujamel, T; Arthur, JC; Campbell, BJ; Dogan, B; Fan, TJ; Fodor, AA; Hansen, JJ; Jobin, C; Keku, TO; Mühlbauer, M; Perez-Chanona, E; Rhodes, JM; Rogers, AB; Simpson, KW; Stintzi, A; Tomkovich, S; Uronis, JM | 1 |
Backman, V; DelaCruz, M; Du, H; Kunte, DP; Menon, A; Patel, A; Roy, HK; Stypula, Y; Wali, RK | 1 |
Kitamura, T; Matsuura, M; Mutoh, M; Niho, N; Sato, H; Sugimura, T; Takahashi, M; Wakabayashi, K | 1 |
Fujii, C; Kagaya, T; Kaneko, S; Kitamura, K; Kondo, T; Mukaida, N; Oshima, M; Popivanova, BK; Wu, Y | 1 |
Shamsuddin, AK; Trump, BF | 1 |
Baba, M; Iishi, H; Nakaizumi, A; Tatsuta, M; Uehara, H; Yano, H | 1 |
Esumi, H; Kato, T; Minamoto, T; Takahashi, M; Yamashita, N; Yazawa, K | 1 |
Asamoto, M; Baba-Toriyama, H; Kakizoe, T; Kim, DJ; Krutovskikh, V; Masuda, M; Moore, MA; Nakamura, J; Nishino, H; Ota, T; Sekine, K; Sugimoto, H; Takasuka, N; Tsuda, H; Watanabe, E | 1 |
Aliaga, C; Braley, J; Pittman, B; Reinhardt, J; Rivenson, A; Weisburger, JH; Zang, E | 1 |
Given, R; Singh, P; Varro, A; Velasco, M; Wang, TC | 1 |
Azuma, N; Iwami, K; Kanamoto, R; Saeki, T; Suda, H; Tsuchihashi, Y | 1 |
Hasegawa, J; Kawasaki, H; Kishimoto, Y; Morisawa, T; Shiota, G; Yashima, K | 1 |
Ahn, BO; Green, J; Hahm, KB; Han, SU; Hong, WS; Kim, MW; Kim, SJ; Kim, YB; Lee, KM; Lee, MH; Lee, WH; Oh, TY | 1 |
Bell, PR; Clayton, HA; Neoptolemos, JP; Nicholson, ML; Talbot, IC | 1 |
Baba, M; Iishi, H; Taniguchi, H; Tatsuta, M | 1 |
Hamilton, SR; Hyland, J; Luk, GD; McAvinchey, D; O'Ceallaigh, D; Smith, JA; Yang, P | 1 |
30 other study(ies) available for azoxymethane and Carcinoma
Article | Year |
---|---|
AOM/DSS Induced Colitis-Associated Colorectal Cancer in 14-Month-Old Female Balb/C and C57/Bl6 Mice-A Pilot Study.
Topics: Animals; Azoxymethane; Carcinogenesis; Carcinoma; Colitis; Colitis-Associated Neoplasms; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pilot Projects | 2022 |
Palmitoyl piperidinopiperidine, a novel derivative of 10‑hydroxy‑2‑decenoic acid, as a potent and selective anticancer agent against human colon carcinoma cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azoxymethane; Carcinogens; Carcinoma; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Colonic Neoplasms; Fatty Acids, Monounsaturated; Female; Humans; Inhibitory Concentration 50; Male; Mice; Molecular Docking Simulation; Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
Geminin ablation in vivo enhances tumorigenesis through increased genomic instability.
Topics: Adenoma; Animals; Ataxia Telangiectasia Mutated Proteins; Azoxymethane; Carcinoma; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Geminin; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Genomic Instability; Histones; Lung Neoplasms; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Phosphorylation; Urethane | 2018 |
Deletion of cadherin-17 enhances intestinal permeability and susceptibility to intestinal tumour formation.
Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; Adenoma; Animals; Azoxymethane; Cadherins; Carcinoma; Cell Cycle Proteins; Colitis; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Gene Deletion; Genetic Predisposition to Disease; Intestinal Absorption; Intestinal Mucosa; Mice, Inbred C57BL; Mice, Knockout; Permeability; Phenotype; Phosphoproteins; Signal Transduction; Tumor Suppressor Proteins; YAP-Signaling Proteins | 2018 |
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Topics: Animals; Azoxymethane; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabis; Carcinogenesis; Carcinoma; Cell Proliferation; Cell Survival; CHO Cells; Colonic Neoplasms; Cricetinae; Cricetulus; Epithelial Cells; HCT116 Cells; Humans; Male; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Random Allocation; Receptors, Cannabinoid; Xenograft Model Antitumor Assays | 2014 |
Dynamic changes and functions of macrophages and M1/M2 subpopulations during ulcerative colitis-associated carcinogenesis in an AOM/DSS mouse model.
Topics: Animals; Azoxymethane; Biomarkers; Carcinoma; Cell Transformation, Neoplastic; Colitis, Ulcerative; Colonic Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; Gene Expression; Hyperplasia; Inflammation Mediators; Macrophages; Male; Mice; Neoplasm Metastasis | 2015 |
Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth.
Topics: Animals; Animals, Congenic; Azoxymethane; Carcinoma; Cell Count; Cell Transformation, Neoplastic; Cells, Cultured; Colitis; Colonic Neoplasms; Dextran Sulfate; Epithelial Cells; Humans; Inflammatory Bowel Diseases; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Intestinal Mucosa; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Proto-Oncogene Proteins c-kit; Receptors, Interleukin; Regeneration; Serine Endopeptidases; Species Specificity; Specific Pathogen-Free Organisms | 2015 |
Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis.
Topics: Animals; Azoxymethane; Caco-2 Cells; Carcinogenesis; Carcinoma; Cell Line, Tumor; Colitis; Colon; Colonic Neoplasms; Cytidine Deaminase; Cytokines; DEAD-box RNA Helicases; Dextran Sulfate; Fibroblasts; Flow Cytometry; HCT116 Cells; HT29 Cells; Humans; Immunoblotting; Immunohistochemistry; Inflammation; Interleukin-1alpha; Interleukin-1beta; Mice; MicroRNAs; Ribonuclease III; Tumor Necrosis Factor-alpha | 2017 |
Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins.
Topics: Alkylating Agents; Alkylation; Animals; Apoptosis; Azoxymethane; Carcinogens; Carcinoma; Colonic Neoplasms; Dextran Sulfate; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Genes, APC; Genetic Predisposition to Disease; Mice; Mice, Inbred C57BL; Mice, Knockout; Tumor Suppressor Proteins | 2009 |
(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinoma; Catechin; Cholesterol; Colonic Neoplasms; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Insulin; Intestinal Mucosa; Leptin; Male; Mice; Mice, Inbred C57BL; Precancerous Conditions; Receptor, IGF Type 1; Triglycerides | 2008 |
Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Carcinogens; Carcinoma; Colonic Neoplasms; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Intestinal Mucosa; Male; Nitric Oxide Synthase Type II; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344; Silybin; Silymarin | 2008 |
Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Azoxymethane; Carcinogens; Carcinoma; Cell Transformation, Neoplastic; Colonic Neoplasms; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Immunity, Innate; Inflammation Mediators; Male; Neoplasms, Experimental; Rats; Rats, Wistar; Time Factors | 2010 |
Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
Topics: Angiogenic Proteins; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Azoxymethane; Carcinogens; Carcinoma; Cell Proliferation; Colonic Neoplasms; Cytoprotection; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Inflammation Mediators; Male; Mice; Mice, Inbred Strains; Silybin; Silymarin | 2010 |
MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model.
Topics: Animals; Azoxymethane; Carcinoma; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Repressor Proteins | 2011 |
Intestinal inflammation targets cancer-inducing activity of the microbiota.
Topics: Animals; Azoxymethane; Carcinogens; Carcinoma; Cell Transformation, Neoplastic; Colitis; Colorectal Neoplasms; DNA Damage; Escherichia coli; Interleukin-10; Intestines; Metagenome; Mice; Mice, Mutant Strains; Polyketide Synthases; Sequence Deletion | 2012 |
Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening.
Topics: Animals; Area Under Curve; Azoxymethane; Biomarkers, Tumor; Biopsy; Carcinogens; Carcinoma; Colonic Neoplasms; Down-Regulation; Early Detection of Cancer; Feces; Humans; Intestinal Mucosa; Male; MicroRNAs; Predictive Value of Tests; Rats; Up-Regulation | 2012 |
Suppression of azoxymethane-induced colon cancer development in rats by a cyclooxygenase-1 selective inhibitor, mofezolac.
Topics: Animals; Azoxymethane; Carcinoma; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Isoxazoles; Male; Membrane Proteins; Rats; Rats, Inbred F344 | 2006 |
Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.
Topics: Animals; Azoxymethane; Carcinoma; Cell Transformation, Neoplastic; Chronic Disease; Colitis, Ulcerative; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Etanercept; Immunoglobulin G; Mice; Mice, Mutant Strains; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 2008 |
Colon epithelium. II. In vivo studies of colon carcinogenesis. Light microscopic, histochemical, and ultrastructural studies of histogenesis of azoxymethane-induced colon carcinomas in Fischer 344 rats.
Topics: Animals; Azo Compounds; Azoxymethane; Carcinoma; Colonic Neoplasms; Epithelium; Intestinal Mucosa; Male; Neoplasms, Experimental; Precancerous Conditions; Rats; Rats, Inbred F344 | 1981 |
Chemoprevention by galanin against colon carcinogenesis induced by azoxymethane in Wistar rats.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinoma; Cell Division; Colonic Neoplasms; Galanin; Neuropeptides; Peptides; Rats; Rats, Wistar | 1995 |
Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinoma; Cholesterol; Colorectal Neoplasms; Docosahexaenoic Acids; Fatty Acids; Male; Rats; Rats, Inbred F344; Triglycerides | 1994 |
Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Azoxymethane; Carcinoma; Cattle; Colonic Neoplasms; Incidence; Intestinal Neoplasms; Intestine, Large; Intestine, Small; Lactoferrin; Male; Rats; Rats, Inbred F344 | 1997 |
Effect of black tea on azoxymethane-induced colon cancer.
Topics: Animals; Azoxymethane; Carcinogens; Carcinoma; Carcinoma in Situ; Colonic Neoplasms; Dose-Response Relationship, Drug; Incidence; Male; Neoplasm Invasiveness; Peyer's Patches; Rats; Rats, Inbred F344; Tea; Time Factors | 1998 |
Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen.
Topics: Adenoma; Amides; Animals; Azoxymethane; Carcinogens; Carcinoma; Colonic Neoplasms; Gastrins; Incidence; Mice; Mice, Transgenic; Neoplasms, Multiple Primary; Protein Precursors; Reference Values; Survival Analysis | 2000 |
Non-involvement of the K-ras mutation in colon carcinogenesis promoted by dietary deoxycholate in azoxymethane-treated rats.
Topics: Animals; Azoxymethane; Carcinogens; Carcinoma; Colonic Neoplasms; Deoxycholic Acid; Diet; Genes, ras; Mutation; Polymorphism, Single-Stranded Conformational; Rats; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane.
Topics: Animals; Azoxymethane; Carcinogens; Carcinoma; Colonic Neoplasms; Cyclooxygenase Inhibitors; Genes, APC; Genes, myc; Immunohistochemistry; Male; Models, Animal; Nitrobenzenes; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides | 2002 |
Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice.
Topics: Animals; Azoxymethane; Carcinogens; Carcinoma; Colonic Neoplasms; Disease Susceptibility; Gastritis; Helicobacter Infections; Helicobacter pylori; Mice; Mice, Transgenic; Receptors, Transforming Growth Factor beta; Signal Transduction; Stomach Neoplasms; Transforming Growth Factor beta | 2002 |
Inhibition of experimental colorectal carcinogenesis by dietary N-6 polyunsaturated fats.
Topics: Adenoma; Adipose Tissue; Animals; Arachidonic Acid; Arachidonic Acids; Azoxymethane; Carcinoma; Cell Membrane; Colorectal Neoplasms; Fats, Unsaturated; Fatty Acids; Intestinal Mucosa; Linoleic Acid; Linoleic Acids; Male; Oleic Acid; Oleic Acids; Palmitic Acid; Palmitic Acids; Rats; Rats, Inbred Strains; Stearic Acids; Weight Gain | 1990 |
Tissue norepinephrine depletion as a mechanism for cysteamine inhibition of colon carcinogenesis induced by azoxymethane in Wistar rats.
Topics: Adenocarcinoma; Adenoma; Animals; Azoxymethane; Carcinoma; Cell Division; Colon; Colonic Neoplasms; Cysteamine; Gastrins; Male; Norepinephrine; Rats; Rats, Inbred Strains | 1989 |
Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat.
Topics: Animals; Azo Compounds; Azoxymethane; Carcinoma; Cell Cycle; Colonic Neoplasms; Enzyme Induction; Intestinal Mucosa; Kinetics; Male; Ornithine Decarboxylase; Rats | 1986 |